Rebound activation of 5-HT neurons following SSRI discontinuation

Rebound activation of 5-HT neurons following SSRI discontinuation

Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling discontinuation syndrome, the mechanism of which is surprisingly little investigated. Here we determined the effect on 5-HT neurochemistry of discontinuation from th...

Descripció completa

Dades bibliogràfiques
Autors principals:	Collins, HM, Gullino, LS, Ozdemir, D, Lazarenco, C, Sudarikova, Y, Daly, E, Pilar Cuéllar, F, Pinacho, R, Bannerman, DM, Sharp, T
Format:	Journal article
Idioma:	English
Publicat:	Springer Nature [academic journals on nature.com] 2024

Ítems similars

Investigation of the behavioural and neurobiological effects of SSRI discontinuation in mice
per: Collins, HM
Publicat: (2023)

Continuous home cage monitoring of activity and sleep in mice during repeated paroxetine treatment and discontinuation
per: Collins, HM, et al.
Publicat: (2023)

Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
per: Collins, H, et al.
Publicat: (2022)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
per: Boothman, L, et al.
Publicat: (2006)

Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate co-transmission
per: Sengupta, A, et al.
Publicat: (2017)

Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
per: Castro, E, et al.
Publicat: (2003)

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission.
per: Cowen, P, et al.
Publicat: (1997)

Augmentation of SSRI treatment
per: Cowen, P
Publicat: (2008)

SSRI-induced hyponatremia
per: Archana Javadekar, et al.
Publicat: (2014-01-01)

Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
per: Eliasz Panek, et al.
Publicat: (2023-04-01)

SSRI Facilitated Crack Dancing
per: Ravi Doobay, et al.
Publicat: (2017-01-01)

A possible role for 5-HT2C receptors in postsynaptic feedback regulation of 5 HT neurones
per: Raley, J, et al.
Publicat: (2006)

To rebound or not to rebound
per: Bethany A Stahl, et al.
Publicat: (2017-10-01)

Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation
per: D. Barouch, et al.
Publicat: (2019-12-01)

NEUROBIOLOGICAL EFFECTS OF ALTERED 5-HT TRANSPORTER EXPRESSION: IMPLICATIONS FOR DEPRESSION AND ANXIETY
per: Sharp, T, et al.
Publicat: (2010)

Neurobiological effects of increased expression of the 5-HT transporter
per: Sharp, T, et al.
Publicat: (2008)

Enhanced discriminative aversive learning and amygdala responsivity in 5-HT transporter mutant mice
per: Lima, J, et al.
Publicat: (2019)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
per: Thibault eRenoir
Publicat: (2013-04-01)

Stimulant and SSRI Medication Trends in ADHD
per: J Gordon Millichap
Publicat: (2001-06-01)

Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
per: Qiang Fu, et al.
Publicat: (2023-09-01)

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
per: Boothman, L, et al.
Publicat: (2006)

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
per: Quérée, P, et al.
Publicat: (2009)

Enhanced discriminative aversive learning and amygdala responsivity in 5-HT transporter mutant mice
per: Lima, J, et al.
Publicat: (2019)

Nicotine inhibits firing activity of dorsal raphe 5-HT neurones in vivo.
per: Engberg, G, et al.
Publicat: (2000)

Differences between SSRI and SNRI in depression treatment
per: Mateusz Grego, et al.
Publicat: (2025-01-01)

Ssri-treated psychiatric disorders prediction with AI
per: A. Mereu
Publicat: (2021-04-01)

Serotonin Syndrome Due to Overdose Intake of SSRI
per: Yavuz Orak, et al.
Publicat: (2015-08-01)

SSRI use in pregnancy: Evaluating the risks and benefits
per: Elsa du Toit, et al.
Publicat: (2015-05-01)

Important messages in the 'post': recent discoveries in 5-HT neurone feedback control.
per: Sharp, T, et al.
Publicat: (2007)

A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats
per: Jocelien D. A. Olivier, et al.
Publicat: (2023-09-01)

Post-Inhibitory Rebound Firing of Dorsal Root Ganglia Neurons
per: Zhu T, et al.
Publicat: (2022-07-01)

Activation of 5-HT(6) receptors facilitates attentional set shifting.
per: Burnham, K, et al.
Publicat: (2010)

Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
per: Jolan Dupont, et al.
Publicat: (2022-06-01)

Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
per: John J Bissler, et al.
Publicat: (2018-01-01)

SSRI induced hypnic jerks: A case series
per: Rakesh Kumar, et al.
Publicat: (2023-07-01)

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
per: Quested, D, et al.
Publicat: (1997)

Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence
per: David Healy, et al.
Publicat: (2024-01-01)

SSRI-associated apathy in Alzheimer's disease: a case series
per: D. S. Petelin, et al.
Publicat: (2022-08-01)

Sustainable surgical resource initiative for Haiti: the SSRI-Haiti project
per: Richard Frechette, et al.
Publicat: (2023-12-01)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
per: Åsa Edvinsson, et al.
Publicat: (2020-01-01)